CONTEXT: Total pancreatectomy with islet auto transplantation (TPIAT) is a treatment for medically refractory chronic pancreatitis that can prevent postsurgical diabetes in some patients. Predictors of insulin independence are needed for appropriate patient selection and counseling. OBJECTIVE: To explore glycemic predictors of insulin independence after TPIAT. DESIGN: A prospective cohort of patients. METHODS: We investigated 34 patients undergoing TPIAT from 2011-2016 at Johns Hopkins Hospital, all had a 75-g oral glucose tolerance test (OGTT) administered prior to their TPIAT. The primary outcome was insulin independence 1 year after TPIAT. RESULTS: Ten of 34 (29%) patients were insulin independent 1 year after TPIAT. All patients with impaired fasting glucose and/or impaired glucose tolerance preoperatively were insulin dependent at 1 year. In age-adjusted regression analyses, fasting glucose ≤ 90 mg/dL [odds ratio (OR) = 6.56; 1.11 to 38.91; P = 0.04], 1-hour OGTT glucose ≤ 143 mg/dL (OR = 6.65; 1.11 to 39.91; P = 0.04), and 2-hour OGTT glucose ≤ 106 mg/dL (OR = 11.74; 1.46 to 94.14; P = 0.02) were significant predictors of insulin independence. In receiver operating characteristic analyses, homeostatic model assessment of β-cell function (HOMA-β) was the most robust predictor of insulin independence [area under the curve (AUC) = 0.88; 0.73 to 1.00]. CONCLUSIONS: Normal preoperative glucose status and lower fasting and postchallenge OGTT glucose values are significant predictors of insulin independence after TPIAT. Higher islet function (HOMA-β) was the strongest predictor. OGTT testing may be a useful tool to aid in patient counseling prior to TPIAT and should be further investigated.
CONTEXT: Total pancreatectomy with islet auto transplantation (TPIAT) is a treatment for medically refractory chronic pancreatitis that can prevent postsurgical diabetes in some patients. Predictors of insulin independence are needed for appropriate patient selection and counseling. OBJECTIVE: To explore glycemic predictors of insulin independence after TPIAT. DESIGN: A prospective cohort of patients. METHODS: We investigated 34 patients undergoing TPIAT from 2011-2016 at Johns Hopkins Hospital, all had a 75-g oral glucose tolerance test (OGTT) administered prior to their TPIAT. The primary outcome was insulin independence 1 year after TPIAT. RESULTS: Ten of 34 (29%) patients were insulin independent 1 year after TPIAT. All patients with impaired fasting glucose and/or impaired glucose tolerance preoperatively were insulin dependent at 1 year. In age-adjusted regression analyses, fasting glucose ≤ 90 mg/dL [odds ratio (OR) = 6.56; 1.11 to 38.91; P = 0.04], 1-hour OGTT glucose ≤ 143 mg/dL (OR = 6.65; 1.11 to 39.91; P = 0.04), and 2-hour OGTT glucose ≤ 106 mg/dL (OR = 11.74; 1.46 to 94.14; P = 0.02) were significant predictors of insulin independence. In receiver operating characteristic analyses, homeostatic model assessment of β-cell function (HOMA-β) was the most robust predictor of insulin independence [area under the curve (AUC) = 0.88; 0.73 to 1.00]. CONCLUSIONS: Normal preoperative glucose status and lower fasting and postchallenge OGTT glucose values are significant predictors of insulin independence after TPIAT. Higher islet function (HOMA-β) was the strongest predictor. OGTT testing may be a useful tool to aid in patient counseling prior to TPIAT and should be further investigated.
Authors: Neil H Bhayani; Laura M Enomoto; Jennifer L Miller; Gail Ortenzi; Jussuf T Kaifi; Eric T Kimchi; Kevin F Staveley-O'Carroll; Niraj J Gusani Journal: HPB (Oxford) Date: 2013-08-29 Impact factor: 3.647
Authors: M'Balu A Webb; Severine C Illouz; Cristina A Pollard; Robert Gregory; John F Mayberry; Simon G Tordoff; Margaret Bone; Christine J Cordle; David P Berry; Michael L Nicholson; Patrick P Musto; Ashley R Dennison Journal: Pancreas Date: 2008-10 Impact factor: 3.327
Authors: Philip C Johnston; Yu Kuei Lin; R Matthew Walsh; Rita Bottino; Tyler K Stevens; Massimo Trucco; James Bena; Charles Faiman; Betul A Hatipoglu Journal: J Clin Endocrinol Metab Date: 2015-03-17 Impact factor: 5.958
Authors: Syed A Ahmad; Andrew M Lowy; Curtis J Wray; David D'Alessio; Kywran A Choe; Laura E James; Andreas Gelrud; Jeffrey B Matthews; Horacio L R Rilo Journal: J Am Coll Surg Date: 2005-09-23 Impact factor: 6.113
Authors: David E R Sutherland; David M Radosevich; Melena D Bellin; Bernard J Hering; Gregory J Beilman; Ty B Dunn; Srinath Chinnakotla; Selwyn M Vickers; Barbara Bland; A N Balamurugan; Martin L Freeman; Timothy L Pruett Journal: J Am Coll Surg Date: 2012-03-06 Impact factor: 6.113
Authors: Michael C Young; Jake R Theis; James S Hodges; Ty B Dunn; Timothy L Pruett; Srinath Chinnakotla; Sidney P Walker; Martin L Freeman; Guru Trikudanathan; Mustafa Arain; Paul R Robertson; Joshua J Wilhelm; Sarah J Schwarzenberg; Barbara Bland; Gregory J Beilman; Melena D Bellin Journal: Pancreas Date: 2016-08 Impact factor: 3.327
Authors: Sarah E Swauger; Lindsey N Hornung; Deborah A Elder; Appakalai N Balamurugan; David S Vitale; Tom K Lin; Jaimie D Nathan; Maisam Abu-El-Haija Journal: Diabetes Care Date: 2022-02-01 Impact factor: 19.112
Authors: Boris Draznin; Vanita R Aroda; George Bakris; Gretchen Benson; Florence M Brown; RaShaye Freeman; Jennifer Green; Elbert Huang; Diana Isaacs; Scott Kahan; Jose Leon; Sarah K Lyons; Anne L Peters; Priya Prahalad; Jane E B Reusch; Deborah Young-Hyman Journal: Diabetes Care Date: 2022-01-01 Impact factor: 19.112
Authors: Varvara A Kirchner; Ty B Dunn; Gregory J Beilman; Srinath Chinnakotla; Timothy L Pruett; Joshua J Wilhelm; Sarah J Schwarzenberg; Martin L Freeman; Melena D Bellin Journal: Curr Treat Options Gastroenterol Date: 2017-12
Authors: Guru Trikudanathan; B Joseph Elmunzer; Yi Yang; Maisam Abu-El-Haija; David Adams; Syed Ahmad; Appakalai N Balamurugan; Gregory J Beilman; Srinath Chinnakotla; Darwin L Conwell; Martin L Freeman; Timothy B Gardner; Betul Hatipoglu; James S Hodges; Varvara Kirchner; Luis F Lara; Leslie Long-Simpson; Rebecca Mitchell; Katherine Morgan; Jaimie D Nathan; Bashoo Naziruddin; Andrew Posselt; Timothy L Pruett; Sarah J Schwarzenberg; Vikesh K Singh; Kerrington Smith; Martin Wijkstrom; Piotr Witkowski; Melena D Bellin Journal: Pancreatology Date: 2020-11-24 Impact factor: 3.996